Webinar
The nexus of terrorism, radicalized insiders and workplace violence
- Global
- Creating a Secure Organisation
- Creating a Resilient Organisation
- Resolving Critical Issues and Crises
The nexus of terrorism, radicalized insiders and workplace violence
Hear from the country’s leading experts in the field of active shooter, radicalization, and behavioral profiles. During this webcast, we share best practices for identifying threats within the workplace, and controls for responding to incidents, should they occur.
Key Topics
- Workplace Violence
- Crisis Management
- Terrorism
Authors
- Shawn VanSlyke, Director
- Oliver Wack, Director
Access the webinar
Fill in your details below to access a recording of the webinar.
Show More
Hide
Authors
You may also be interested in
Report
CORE political violence and violent organised crime report Q4 2020
We are pleased to release our forth quarter report on political violence and violent organised crime incidents around the world. This report draws upon and highlights the extensive incident mapping data and analysis that is available within CORE, the essential risk monitoring toolkit from Control Risks.
The Global Insight
The new American threat landscape
Join Charles Hecker and Control Risks experts Jonathan Wood and Shawn VanSlyke for a discussion about the implications of the 6 January storming of the US Capitol for the US security environment.
Analysis
RiskMap 2021: The legal and compliance perspective
As we move into 2021, legal and compliance teams – like the companies they work for – undoubtedly face challenges. Find out more about the five key issues for the upcoming year.
Analysis
2021 will change how private market investors consider deals
Our RiskMap coverage shows that dealmakers need to have a range of issues in mind as they consider transactions in 2021. Find out more about the three key considerations here.
The Global Insight
Vaccines: the road ahead
Join Charles Hecker and Control Risks experts Caroline Naumann and Joseph Smith for a conversation about the unique challenges facing the global rollout of COVID-19 vaccines.